IDH1-MUTANT GLIOMA

Clinical trials for IDH1-MUTANT GLIOMA explained in plain language.

Never miss a new study

Get alerted when new IDH1-MUTANT GLIOMA trials appear

Sign up with your email to follow new studies for IDH1-MUTANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for brain tumor patients: targeted drug enters final testing phase

Disease control Recruiting now

This study tests a drug called safusidenib in people with a slow-growing brain tumor (glioma) that has a specific IDH1 gene mutation. The trial has three parts: one for recurrent tumors, one to see if the drug can prevent tumor growth after standard treatment, and one for a speci…

Matched conditions: IDH1-MUTANT GLIOMA

Phase: PHASE3 • Sponsor: Nuvation Bio Inc. • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

IDH1-MUTANT GLIOMA

Get alerted when new IDH1-MUTANT GLIOMA trials appear

New hope for brain tumor patients: targeted drug enters final testing phase